A detailed history of Hardman Johnston Global Advisors LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Hardman Johnston Global Advisors LLC holds 305,256 shares of EW stock, worth $20.2 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
305,256
Previous 315,571 3.27%
Holding current value
$20.2 Million
Previous $29.1 Million 30.9%
% of portfolio
0.82%
Previous 1.17%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$59.7 - $93.78 $615,805 - $967,340
-10,315 Reduced 3.27%
305,256 $20.1 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $894,423 - $1 Million
-10,610 Reduced 3.25%
315,571 $29.1 Million
Q1 2024

May 06, 2024

SELL
$72.54 - $95.56 $129,846 - $171,052
-1,790 Reduced 0.55%
326,181 $31.2 Million
Q4 2023

Jan 29, 2024

SELL
$61.71 - $77.76 $213,208 - $268,660
-3,455 Reduced 1.04%
327,971 $25 Million
Q3 2023

Oct 20, 2023

SELL
$69.28 - $93.38 $262,571 - $353,910
-3,790 Reduced 1.13%
331,426 $23 Million
Q2 2023

Aug 11, 2023

SELL
$81.41 - $94.33 $667,236 - $773,128
-8,196 Reduced 2.39%
335,216 $31.6 Million
Q1 2023

May 05, 2023

SELL
$74.26 - $84.51 $15.4 Million - $17.5 Million
-207,316 Reduced 37.64%
343,412 $28.4 Million
Q4 2022

Feb 03, 2023

SELL
$68.3 - $87.44 $8.3 Million - $10.6 Million
-121,470 Reduced 18.07%
550,728 $41.1 Million
Q3 2022

Nov 02, 2022

BUY
$82.37 - $107.29 $5.39 Million - $7.02 Million
65,404 Added 10.78%
672,198 $55.5 Million
Q2 2022

Aug 02, 2022

SELL
$86.5 - $128.27 $556,195 - $824,776
-6,430 Reduced 1.05%
606,794 $57.7 Million
Q1 2022

May 12, 2022

SELL
$101.96 - $128.34 $5.86 Million - $7.37 Million
-57,430 Reduced 8.56%
613,224 $72.2 Million
Q4 2021

Jan 26, 2022

SELL
$106.37 - $130.68 $1.97 Million - $2.42 Million
-18,520 Reduced 2.69%
670,654 $86.9 Million
Q3 2021

Nov 12, 2021

SELL
$102.91 - $122.75 $5.7 Million - $6.8 Million
-55,420 Reduced 7.44%
689,174 $78 Million
Q2 2021

Aug 09, 2021

BUY
$83.84 - $104.76 $2.96 Million - $3.7 Million
35,325 Added 4.98%
744,594 $77.1 Million
Q1 2021

May 12, 2021

SELL
$78.68 - $90.67 $185,684 - $213,981
-2,360 Reduced 0.33%
709,269 $59.3 Million
Q4 2020

Feb 11, 2021

SELL
$71.69 - $91.23 $441,610 - $561,976
-6,160 Reduced 0.86%
711,629 $64.9 Million
Q3 2020

Nov 16, 2020

BUY
$67.19 - $87.44 $2.76 Million - $3.6 Million
41,135 Added 6.08%
717,789 $57.3 Million
Q2 2020

Jul 23, 2020

BUY
$57.54 - $76.95 $26 Million - $34.8 Million
452,696 Added 202.13%
676,654 $46.8 Million
Q1 2020

May 04, 2020

BUY
$52.41 - $81.0 $72,325 - $111,780
1,380 Added 0.62%
223,958 $42.2 Million
Q4 2019

Feb 05, 2020

SELL
$71.7 - $82.09 $760,593 - $870,810
-10,608 Reduced 4.55%
222,578 $51.9 Million
Q3 2019

Oct 30, 2019

SELL
$61.55 - $75.43 $2.63 Million - $3.22 Million
-42,740 Reduced 15.49%
233,186 $51.3 Million
Q2 2019

Aug 05, 2019

SELL
$55.74 - $64.41 $1.12 Million - $1.3 Million
-20,140 Reduced 6.8%
275,926 $51 Million
Q1 2019

May 03, 2019

SELL
$47.89 - $64.05 $1.32 Million - $1.77 Million
-27,625 Reduced 8.53%
296,066 $56.6 Million
Q4 2018

Feb 06, 2019

SELL
$46.41 - $56.94 $858,584 - $1.05 Million
-18,500 Reduced 5.41%
323,691 $49.6 Million
Q3 2018

Oct 18, 2018

SELL
$45.7 - $58.03 $206,564 - $262,295
-4,520 Reduced 1.3%
342,191 $59.6 Million
Q2 2018

Jul 18, 2018

SELL
$42.45 - $51.3 $1.15 Million - $1.39 Million
-27,130 Reduced 7.26%
346,711 $50.5 Million
Q1 2018

Apr 30, 2018

SELL
$37.19 - $47.45 $190,040 - $242,469
-5,110 Reduced 1.35%
373,841 $52.2 Million
Q4 2017

Jan 26, 2018

SELL
$33.79 - $39.39 $51,360 - $59,872
-1,520 Reduced 0.4%
378,951 $42.7 Million
Q3 2017

Oct 30, 2017

BUY
$36.29 - $38.83 $40,644 - $43,489
1,120 Added 0.3%
380,471 $41.6 Million
Q2 2017

Aug 14, 2017

BUY
N/A
379,351
379,351 $44.9 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $40.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Hardman Johnston Global Advisors LLC Portfolio

Follow Hardman Johnston Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hardman Johnston Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hardman Johnston Global Advisors LLC with notifications on news.